TREM2 and Alzheimer disease: We hypothesize brain lipid dysregulation in AD reflects unresolved pathologies (damaged myelin, stressed/dying neurons and their knock-on impacts on lipid metabolism and membrane composition) exacerbated in people with TREM2 risk variants where microglia fail to recognize and clear these pathologies effectively.